Related Experiment Video
Updated: Jan 14, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Comprehensive Review of Phytotherapeutic Methods for Treating tuberculosis
Reetu Chauhan1, Shikha Sharma1, Jagdish K Sahu2
1Department of Pharmaceutical Science, Lords University, Chikani, Alwar, 301028, Rajasthan, India.
Medicinal plants offer novel treatments for tuberculosis (TB), including drug-resistant strains. Their phytochemicals show promise against Mycobacterium tuberculosis, addressing the urgent need for new anti-TB drugs.
Area of Science:
- Phytochemistry
- Microbiology
- Pharmacology
Background:
- Tuberculosis (TB) incidence is rising globally, driven by drug-resistant Mycobacterium tuberculosis strains.
- Existing first-line and second-line TB drugs are becoming less effective due to resistance.
- Multi-Drug-Resistant (MDR) and extensively-Drug-Resistant (XDR) TB necessitate novel therapeutic agents.
Purpose of the Study:
- To review current synthetic drugs for TB treatment.
- To highlight the potential of medicinal plants and their phytochemicals in combating TB.
- To explore alternative sources for novel anti-TB drug development.
Main Methods:
- Literature review of current synthetic TB drugs.
- Survey of research on medicinal plants with anti-tubercular activity.
- Analysis of phytochemical constituents with antimicrobial properties.
Main Results:
- Medicinal plants contain secondary metabolites like alkaloids, flavonoids, and terpenoids.
- These phytochemicals exhibit antimicrobial properties effective against Mycobacterium tuberculosis.
- Identified phytochemicals show potential for treating MDR and XDR TB strains.
Conclusions:
- Medicinal plants are a valuable source for discovering new anti-TB agents.
- Phytochemicals from these plants offer a promising strategy against drug-resistant TB.
- Further research into plant-derived compounds is crucial for developing novel TB therapies.
More Related Videos
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
10:29A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...